血常规参数与乳腺癌预后关系的研究进展  

Research progress of the relation between blood routine parameters and prognosis of breast cancer

作　　者：刘燚 李建军[1] Liu Yi;Li Jianjun(Department of Radiotherapy,the First Hospital of China Medical University,Shenyang 110001,China)

机构地区：[1]中国医科大学附属第一医院放疗科,沈阳110001

出　　处：《中国医药》2019年第2期308-311,共4页China Medicine

摘　　要：乳腺癌是我国女性常见恶性肿瘤之一,也是主要的肿瘤死亡原因之一。随着现代医学的发展,乳腺癌的预后越来越好,随之而来的是人们期待对于乳腺癌的预后是否有良好的预测和指导临床治疗的指标。血常规因其具有常规性和经济实用性而在临床中广泛应用,成为一项热门预测指标,近年来对于血常规与乳腺癌预后关系的研究越来越多。本文结合国内外报道,对血常规参数与乳腺癌患者预后关系的研究进展作一综述。Breast cancer is one of the major malignant tumors with a high mortality in China. Modern medical developments have improved the prognosis of breast cancer. Current studies focus on sensitive indexes for the early prediction of prognosis and guidelines of clinical treatments. Blood routine parameters are regular indicators with economic reliability in clinical practice. The relation between blood routine and prognosis of breast cancer has been a research hotspot. This paper reviewed the research progress of the relation between blood routine parameters and prognosis of breast cancer.

关 键 词：乳腺肿瘤 血常规 预后 

分 类 号：R737.9[医药卫生—肿瘤]